Breaking News Instant updates and real-time market news.

BMY

Bristol-Myers

$50.21

0.25 (0.50%)

15:25
09/29/19
09/29
15:25
09/29/19
15:25

Bristol-Myers announces final results from CheckMate -227 Part 1

Bristol-Myers Squibb announced results from Part 1 of the Phase 3 CheckMate -227 trial evaluating Opdivo plus low-dose Yervoy as first-line treatment for patients with advanced non-small cell lung cancer. Opdivo plus low-dose Yervoy met the independent co-primary endpoint of overall survival, demonstrating superior benefit compared to chemotherapy in patients whose tumors expressed PD-L1 greater than or equal to 1%. Additionally, in an exploratory analysis, results showed improved overall survival for patients treated with the combination of Opdivo plus low-dose Yervoy with PD-L1 less than 1%. The two-year survival rate for patients treated with the combination regimen was 40% for both patients whose tumors expressed PD-L1 greater than or equal to1% and patients whose tumors expressed PD-L1 less than1%. In the chemotherapy control arm, two-year survival rates were 33% and 23%, respectively. The safety profile of Opdivo plus low-dose Yervoy was consistent with previously reported studies in NSCLC and no new safety signals were observed. With a minimum follow-up of 29.3 months, patients treated with Opdivo plus low-dose Yervoy, regardless of PD-L1 expression level, experienced a nearly four times longer duration of response compared to patients treated with chemotherapy. In patients with PD-L1 greater than or equal to 1%, the objective response rate was 35.9% with Opdivo plus low-dose Yervoy versus 30.0% with chemotherapy. The median duration of response for the combination therapy arm was 23.2 months versus 6.2 months in the chemotherapy arm. In patients with PD-L1 less than 1%, the objective response rate was 27.3% with Opdivo plus low-dose Yervoy versus 23.1% with chemotherapy, with a median DoR of 18 months for the combination therapy arm versus 4.8 months in the chemotherapy arm.

  • 31

    Oct

BMY Bristol-Myers
$50.21

0.25 (0.50%)

08/14/19
ATLE
08/14/19
UPGRADE
Target $63
ATLE
Overweight
Bristol-Myers upgraded to Overweight from Neutral at Atlantic Equities
Atlantic Equities analyst Steve Chesney upgraded Bristol-Myers Squibb to Overweight from Neutral and raised his price target for the shares to $63 from $51.
08/14/19
08/14/19
UPGRADE

Fly Intel: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Evercore Partners (EVR) upgraded to Neutral from Sell at Goldman Sachs with analyst Richard Ramsden saying believes that stronger U.S. large cap deal activity than he previously expected should support Evercore's revenues. 2. Sanofi (SNY) upgraded to Buy from Neutral at UBS with analyst Laura Sutcliffe saying she sees signs of a turnaround for the company and believes its pipeline can fixed ahead of patent expiration. 3. Bristol-Myers (BMY) upgraded to Overweight from Neutral at Atlantic Equities. 4. Horizon Pharma (HZNP) upgraded to Outperform from Market Perform at BMO Capital with analyst Gary Nachman citing the company's "strong" Q2 results driven by Krystexxa. 5. Ferrari (RACE) upgraded to Buy from Neutral at Goldman Sachs with analyst George Galliers citing the company's Q2 results earlier this month. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/19/19
MZHO
08/19/19
DOWNGRADE
MZHO
Neutral
Amgen, Celgene downgraded to Neutral on valuation at Mizuho
As previously reported, Mizuho analyst Salim Syed downgraded Amgen (AMGN) and Celgene (CELG), each to Neutral from Buy, "solely" on the stock's current trading prices nearing what the analyst views as appropriate valuations. Amgen has run up over the last week by about 10% following a "very clean Enbrel litigation win," but the stock price now gives full credit for its Enbrel IP, said Syed, who raised his price target on Amgen shares to $212 from $208. He also cut his price target on Celgene shares to $100 from $103, based on a calculation of one Bristol-Myers (BMY) share being worth $47, plus $50 cash per share and $3 for a risk-adjusted CVR valuation.
08/27/19
RBCM
08/27/19
NO CHANGE
Target $206
RBCM
Sector Perform
Amgen price target raised to $206 from $192 at RBC Capital
RBC Capital analyst Kennen MacKay raised his price target on Amgen to $206, saying that despite the "sticker shock" of its $13.4B deal for the Otezla franchise, the transaction is expected to be immediately accretive to earnings and fitting well with its existing inflammation and immunology portfolio. The analyst believes that Amgen should be able to grow revenue "majorly" over the next 3 years as it leverages Otezla potential with its legal victory on Enbrel, stating that there is a case for its multiple to re-rate higher. MacKay keeps his Sector Perform rating on Amgen shares as he awaits for its emerging pipeline to also "fill the shoes" of its maturing assets.

TODAY'S FREE FLY STORIES

13:55
10/16/19
10/16
13:55
10/16/19
13:55
Conference/Events
Joint Economic Committee to hold a hearing »

The Committee holds a…

TMUS

T-Mobile

$79.88

0.125 (0.16%)

, S

Sprint

$6.45

-0.03 (-0.46%)

13:52
10/16/19
10/16
13:52
10/16/19
13:52
Periodicals
T-Mobile, Sprint deal 'appears to have cleared' FCC vote, Bloomberg says »

Bloomberg headlines…

TMUS

T-Mobile

$79.88

0.125 (0.16%)

S

Sprint

$6.45

-0.03 (-0.46%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

13:45
10/16/19
10/16
13:45
10/16/19
13:45
General news
Breaking General news story  »

Beige Book to be released…

PNC

PNC Financial

$140.90

1.34 (0.96%)

13:45
10/16/19
10/16
13:45
10/16/19
13:45
Conference/Events
The Brookings Institution to hold a discussion on recession preparation »

Brookings hosts a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

IBM

IBM

$141.89

-1.09 (-0.76%)

, FB

Facebook

$188.69

-0.12 (-0.06%)

13:43
10/16/19
10/16
13:43
10/16/19
13:43
Earnings
Fly Intel: What to watch in IBM's earnings report »

IBM (IBM) is scheduled to…

IBM

IBM

$141.89

-1.09 (-0.76%)

FB

Facebook

$188.69

-0.12 (-0.06%)

V

Visa

$177.59

-1.21 (-0.68%)

PYPL

PayPal

$102.54

-1 (-0.97%)

EBAY

eBay

$38.92

0.04 (0.10%)

MA

MasterCard

$277.70

-0.94 (-0.34%)

BKNG

Booking Holdings

$2,025.61

7.98 (0.40%)

MSFT

Microsoft

$139.94

-1.62 (-1.14%)

GOOG

Alphabet

$1,243.61

0.08 (0.01%)

GOOGL

Alphabet Class A

$1,243.00

0.49 (0.04%)

INTC

Intel

$52.14

-0.505 (-0.96%)

BABA

Alibaba

$176.05

0.74 (0.42%)

SFTBF

SoftBank

$0.00

(0.00%)

BIDU

Baidu

$108.33

1.115 (1.04%)

SCMWY

Swisscom

$0.00

(0.00%)

TCEHY

Tencent

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 18

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 26

    Oct

  • 27

    Oct

  • 28

    Oct

  • 28

    Oct

  • 29

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

  • 06

    Nov

  • 19

    Nov

  • 20

    Nov

  • 21

    Nov

M

Macy's

$15.77

0.07 (0.45%)

13:35
10/16/19
10/16
13:35
10/16/19
13:35
Options
Macy's put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

FB

Facebook

$188.59

-0.22 (-0.12%)

13:32
10/16/19
10/16
13:32
10/16/19
13:32
Hot Stocks
Facebook unveils ReAgent to help build models that make and rely on decisions »

Jason Gauci, Honglei Liu,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

PINS

Pinterest

$25.70

0.1 (0.39%)

13:27
10/16/19
10/16
13:27
10/16/19
13:27
Upgrade
Pivotal upgrades Pinterest to Buy after 30% pullback from highs »

Pivotal Research analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 31

    Oct

  • 19

    Nov

  • 16

    Oct

ALGN

Align Technology

$211.62

2.32 (1.11%)

13:25
10/16/19
10/16
13:25
10/16/19
13:25
Options
Align Technology call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

13:25
10/16/19
10/16
13:25
10/16/19
13:25
Conference/Events
Stephens food/agribusiness analyst to hold analyst/industry conference call »

Analysts, along with…

13:25
10/16/19
10/16
13:25
10/16/19
13:25
Conference/Events
Wedbush technology analyst to hold an analyst/industry webcast »

Technology Analyst…

PINS

Pinterest

$25.69

0.09 (0.35%)

13:21
10/16/19
10/16
13:21
10/16/19
13:21
Upgrade
Pinterest rating change  »

Pinterest upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 31

    Oct

  • 19

    Nov

  • 16

    Oct

PM

Philip Morris

$79.09

0.77 (0.98%)

, HON

Honeywell

$163.93

0.27 (0.16%)

13:19
10/16/19
10/16
13:19
10/16/19
13:19
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

PM

Philip Morris

$79.09

0.77 (0.98%)

HON

Honeywell

$163.93

0.27 (0.16%)

UNP

Union Pacific

$163.27

0.07 (0.04%)

MS

Morgan Stanley

$42.80

0.26 (0.61%)

BBT

BB&T

$52.81

0.06 (0.11%)

STI

SunTrust

$68.01

-0.04 (-0.06%)

PPG

PPG

$119.43

1.21 (1.02%)

MTB

M&T Bank

$158.77

-0.1 (-0.06%)

KEY

KeyCorp

$17.63

-0.15 (-0.84%)

GPC

Genuine Parts

$97.95

0.01 (0.01%)

DOV

Dover

$95.93

-0.02 (-0.02%)

TXT

Textron

$50.56

-0.11 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 04

    Nov

  • 08

    Nov

  • 10

    Nov

  • 11

    Nov

  • 12

    Nov

IBM

IBM

$141.62

-1.36 (-0.95%)

, NFLX

Netflix

$282.05

-2.19 (-0.77%)

13:19
10/16/19
10/16
13:19
10/16/19
13:19
Earnings
Notable companies reporting after market close »

Notable companies…

IBM

IBM

$141.62

-1.36 (-0.95%)

NFLX

Netflix

$282.05

-2.19 (-0.77%)

CCI

Crown Castle

$133.80

-0.85 (-0.63%)

CSX

CSX

$68.89

-0.28 (-0.40%)

KMI

Kinder Morgan

$20.09

-0.09 (-0.45%)

CCK

Crown Holdings

$63.23

0.44 (0.70%)

URI

United Rentals

$122.16

1.45 (1.20%)

STLD

Steel Dynamics

$28.59

-1.53 (-5.08%)

AA

Alcoa

$19.44

-0.01 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 16

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 17

    Oct

  • 27

    Oct

  • 29

    Oct

  • 13

    Nov

FB

Facebook

$188.88

0.07 (0.04%)

, AVGO

Broadcom

$288.01

-2.45 (-0.84%)

13:17
10/16/19
10/16
13:17
10/16/19
13:17
Periodicals
European Commission exploring investigation of Facebook, NY Times reports »

The European Commission…

FB

Facebook

$188.88

0.07 (0.04%)

AVGO

Broadcom

$288.01

-2.45 (-0.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 30

    Oct

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

13:17
10/16/19
10/16
13:17
10/16/19
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

13:16
10/16/19
10/16
13:16
10/16/19
13:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

W

Wayfair

$110.58

1.63 (1.50%)

13:15
10/16/19
10/16
13:15
10/16/19
13:15
Options
Wayfair put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Oct

13:15
10/16/19
10/16
13:15
10/16/19
13:15
Conference/Events
FBN Securities media analyst to hold an analyst/industry conference call »

Media & Entertainment…

FB

Facebook

$188.81

(0.00%)

, V

Visa

$177.55

-1.25 (-0.70%)

13:13
10/16/19
10/16
13:13
10/16/19
13:13
Periodicals
Facebook exec still expects Libra to win enough financial backers, Reuters says »

Facebook's (FB)…

FB

Facebook

$188.81

(0.00%)

V

Visa

$177.55

-1.25 (-0.70%)

MA

MasterCard

$277.35

-1.29 (-0.46%)

PYPL

PayPal

$102.55

-0.99 (-0.96%)

BKNG

Booking Holdings

$2,026.75

9.12 (0.45%)

EBAY

eBay

$38.95

0.07 (0.18%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 16

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 27

    Oct

  • 29

    Oct

  • 29

    Oct

  • 30

    Oct

AKBA

Akebia

$4.46

0.125 (2.89%)

13:10
10/16/19
10/16
13:10
10/16/19
13:10
Recommendations
Akebia analyst commentary  »

Akebia lawsuit against…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEVI

Levi Strauss

$17.50

0.14 (0.81%)

, WWW

Wolverine World Wide

$28.71

0.115 (0.40%)

13:08
10/16/19
10/16
13:08
10/16/19
13:08
Hot Stocks
Wolverine World Wide appoints Angelo Ng as chief merchant officer »

Wolverine World Wide…

LEVI

Levi Strauss

$17.50

0.14 (0.81%)

WWW

Wolverine World Wide

$28.71

0.115 (0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

PDCO

Patterson Companies

$17.44

0.11 (0.63%)

13:06
10/16/19
10/16
13:06
10/16/19
13:06
Hot Stocks
Patterson does not believe FTC recommendation will impact financials »

Patterson Companies…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUN

Huntsman

$23.10

0.1 (0.43%)

13:05
10/16/19
10/16
13:05
10/16/19
13:05
Downgrade
Huntsman rating change  »

Huntsman downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

LSCC

Lattice Semiconductor

$19.52

-0.24 (-1.21%)

13:02
10/16/19
10/16
13:02
10/16/19
13:02
Hot Stocks
Lattice MachXO3D secure control FPGA receives security certification from NIST »

Lattice Semiconductor …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Oct

  • 20

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.